Delivery Order SPE2DB22D2007-SPE2DB25FJ4SF
- Not listed
- The Defense Logistics Agency awarded a $1,092.15 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Savella 50 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,064.07 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 4, 2025, with completion expected by August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Savella 50 mg tablets (60-count units) with a contract value of $26,478.90. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Savella 25 mg tablets (60-count packaging) with a ceiling value of $4,676.17. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,727.50 to AmerisourceBergen Drug Corp for the supply of Savella 100 mg tablets (60-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.34 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 50 mg tablets in a quantity of 60 units. This contract, designated as a firm fixed price delivery order, was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The award represents a non-competitive, non-set-aside transaction and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Savella 50 mg tablets (60 count) under a firm fixed-price contract. The contract, valued at $15,609.03, is scheduled for completion by July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside restrictions, reflecting the contractor's capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Savella (milnacipran) 100 mg tablets in a 60-count quantity. This is a firm fixed-price, non-set-aside contract with a ceiling value of $3,669.15 and an ultimate completion date of July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a $2,111.57 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, a neurological medication used in pain management. This competitive contract, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $4,806.61 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, a medication primarily used for fibromyalgia treatment. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4SFDelivery Order
The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The contract vehicle enables the company to fulfill federal medical supply needs across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's established capability to meet federal procurement requirements through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/5/25 |